Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学NSCLC, MET and ALK Europe

Frederic Barlesi

MD, PhD

🏢Gustave Roussy Cancer Campus🌐France

Head of Medical Oncology Department

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Frederic Barlesi is a leading French thoracic oncologist who has contributed to multiple pivotal NSCLC trials including studies of capmatinib in MET exon 14-altered disease and ALK inhibitors in European populations. He leads genomic profiling initiatives in France and directs comprehensive molecular testing programs for patients with advanced NSCLC. His research explores combinations of targeted therapies with immunotherapy in ALK-positive and MET-driven cancers. He holds leadership positions in ESMO and other European oncology organizations.

Share:

🧪Research Fields 研究领域

capmatinib
METex14 NSCLC Europe
ALK European trials
comprehensive genomic profiling France
immunotherapy combinations ALK

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Frederic Barlesi 的研究动态

Follow Frederic Barlesi's research updates

留下邮箱,当我们发布与 Frederic Barlesi(Gustave Roussy Cancer Campus)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment